# Escitalopram and Language Intervention for Subacute Aphasia

> **NCT03843463** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 88 (estimated)

## Conditions studied

- Aphasia
- Stroke

## Interventions

- **DRUG:** Escitalopram 10mg
- **DRUG:** Placebo
- **BEHAVIORAL:** Computer-delivered naming treatment

## Key facts

- **NCT ID:** NCT03843463
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-18
- **Primary completion:** 2026-09-18
- **Final completion:** 2027-01-18
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2025-09-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843463, "Escitalopram and Language Intervention for Subacute Aphasia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03843463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*